Yifeng Jing

1.4k total citations
47 papers, 995 citations indexed

About

Yifeng Jing is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Yifeng Jing has authored 47 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Urology. Recurrent topics in Yifeng Jing's work include Urinary Bladder and Prostate Research (12 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Urological Disorders and Treatments (7 papers). Yifeng Jing is often cited by papers focused on Urinary Bladder and Prostate Research (12 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Urological Disorders and Treatments (7 papers). Yifeng Jing collaborates with scholars based in China, United States and North Korea. Yifeng Jing's co-authors include Shujie Xia, Bangmin Han, Di Cui, Chenyi Jiang, Xiaohai Wang, Zhou Wang, Fei Shi, Laura E. Pascal, Dan Wang and Ruizhe Zhao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, New Phytologist and Endocrinology.

In The Last Decade

Yifeng Jing

46 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifeng Jing China 19 442 284 216 172 156 47 995
Zhiwen Chen China 20 562 1.3× 142 0.5× 261 1.2× 94 0.5× 174 1.1× 70 1.0k
Stuart J. Ellem Australia 20 374 0.8× 631 2.2× 222 1.0× 136 0.8× 81 0.5× 28 1.4k
Adam Jones United Kingdom 17 563 1.3× 243 0.9× 391 1.8× 25 0.1× 139 0.9× 29 1.1k
Petra J. de Verdier Sweden 15 394 0.9× 70 0.2× 100 0.5× 102 0.6× 231 1.5× 24 780
Shauh‐Der Yeh Taiwan 10 517 1.2× 93 0.3× 189 0.9× 28 0.2× 74 0.5× 22 995
Heung‐Joong Kim South Korea 23 785 1.8× 30 0.1× 207 1.0× 93 0.5× 76 0.5× 64 1.2k
Karina G. Zecchin Brazil 21 740 1.7× 84 0.3× 526 2.4× 36 0.2× 169 1.1× 32 1.2k
Feifei Sun China 19 513 1.2× 90 0.3× 259 1.2× 12 0.1× 77 0.5× 106 1.1k
Zhengming Wang China 14 495 1.1× 81 0.3× 280 1.3× 15 0.1× 84 0.5× 36 791

Countries citing papers authored by Yifeng Jing

Since Specialization
Citations

This map shows the geographic impact of Yifeng Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Jing more than expected).

Fields of papers citing papers by Yifeng Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Jing. The network helps show where Yifeng Jing may publish in the future.

Co-authorship network of co-authors of Yifeng Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Jing. A scholar is included among the top collaborators of Yifeng Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Jing. Yifeng Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Qian, Xiaoqin Shi, Qingyuan Lin, et al.. (2024). EAF2 Downregulation Recruits Tumor-associated Macrophages in Prostate Cancer through Upregulation of MIF. Biological Procedures Online. 26(1). 21–21. 2 indexed citations
2.
Han, Bangmin, et al.. (2024). Beyond size: A comprehensive overview of small-volume benign prostatic hyperplasia. Current Urology. 19(1). 1–5.
3.
Deng, Zheng, et al.. (2023). Activation of the HNRNPA2B1/miR-93-5p/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner. Journal of Cancer. 14(7). 1242–1256. 17 indexed citations
4.
Yang, Juan, Hongbin Wei, Mei Hou, et al.. (2023). ZmSPL13andZmSPL29act together to promote vegetative and reproductive transition in maize. New Phytologist. 239(4). 1505–1520. 18 indexed citations
5.
Cao, Tianyu, Feng Xie, Yi Liu, et al.. (2023). Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia. International Journal of Biological Sciences. 19(11). 3441–3455. 2 indexed citations
6.
7.
Shi, Fei, Zheng Zhou, Lei Wu, et al.. (2022). Tumor-associated macrophages in direct contact with prostate cancer cells promote malignant proliferation and metastasis through NOTCH1 pathway. International Journal of Biological Sciences. 18(16). 5994–6007. 22 indexed citations
8.
Wei, Hongbin, Yifeng Jing, Lei Zhang, & Dexin Kong. (2021). Phytohormones and their crosstalk in regulating stomatal development and patterning. Journal of Experimental Botany. 72(7). 2356–2370. 37 indexed citations
9.
Kong, Dexin, Yifeng Jing, Yongping Zhao, et al.. (2021). ZmSPL10/14/26 are required for epidermal hair cell fate specification on maize leaf. New Phytologist. 230(4). 1533–1549. 32 indexed citations
10.
Zhou, Dapeng, Di Cui, Juntao Jiang, et al.. (2021). Targeting ADT-Induced Activation of the E3 Ubiquitin Ligase Siah2 to Delay the Occurrence of Castration-Resistant Prostate Cancer. Frontiers in Oncology. 11. 637040–637040. 7 indexed citations
11.
Zhang, Yu, Ziye Zhang, Lina Zhang, et al.. (2020). Clinical Implications of Peripheral CD3+CD69+ T-Cell And CD8+CD28+ T-Cell Proportions in Patients Prior to Radical Prostatectomy.. PubMed. 17(3). 257–261. 1 indexed citations
12.
Yu, Dong, Jingya Sun, Yifeng Jing, et al.. (2020). Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling. BMC Complementary Medicine and Therapies. 20(1). 150–150. 7 indexed citations
13.
Zhang, Yu, Jing Zhao, Mao Ding, et al.. (2020). Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis. Journal of Experimental & Clinical Cancer Research. 39(1). 282–282. 69 indexed citations
14.
Deng, Zheng, Fei Shi, Zheng Zhou, et al.. (2019). M1 macrophage mediated increased reactive oxygen species (ROS) influence wound healing via the MAPK signaling in vitro and in vivo. Toxicology and Applied Pharmacology. 366. 83–95. 81 indexed citations
15.
Zhao, Ruizhe, Xiaohai Wang, Chenyi Jiang, et al.. (2018). Endothelial cells promote metastasis of prostate cancer by enhancing autophagy. Journal of Experimental & Clinical Cancer Research. 37(1). 221–221. 59 indexed citations
16.
Sun, Qian, Wenhuan Guo, Di Cui, et al.. (2018). Thulium laser enucleation versus thulium laser resection of the prostate for prevention of bladder neck contracture in a small prostate: a prospective randomized trial. World Journal of Urology. 37(5). 853–859. 22 indexed citations
17.
Ruan, Yuan, Yifeng Jing, Xiaohai Wang, et al.. (2018). Transurethral thulium laser enucleation versus resection of the prostate for treating benign prostatic hyperplasia: a retrospective study. Lasers in Medical Science. 34(2). 329–334. 16 indexed citations
18.
Zhao, Sheng, Di Cui, Yu Zhang, et al.. (2017). Androgen receptor antagonist bicalutamide induces autophagy and apoptosis via ULK2 upregulation in human bladder cancer cells.. PubMed Central. 10(7). 7603–7615. 4 indexed citations
19.
Jiang, Chenyi, Xingjie Wang, Yuan Ruan, et al.. (2016). Long non-coding RNA lnc-MX1-1 is associated with poor clinical features and promotes cellular proliferation and invasiveness in prostate cancer. Biochemical and Biophysical Research Communications. 470(3). 721–727. 22 indexed citations
20.
Han, Bangmin, Yifeng Jing, Di Cui, et al.. (2014). Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection. Medical Oncology. 31(4). 912–912. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiwen Chen Breakdown of academic impact, for papers by Stuart J. Ellem Breakdown of academic impact, for papers by Adam Jones Breakdown of academic impact, for papers by Petra J. de Verdier Breakdown of academic impact, for papers by Shauh‐Der Yeh Breakdown of academic impact, for papers by Heung‐Joong Kim Breakdown of academic impact, for papers by Karina G. Zecchin Breakdown of academic impact, for papers by Feifei Sun Breakdown of academic impact, for papers by Zhengming Wang
Rankless by CCL
2026